Dr. Ramin Daneshvar, MD

Dr. Daneshvar practices at UF Health Shands Hospital in Gainesville, Florida, part of UF Health.

Dr. Daneshvar's NPI, 1013597947, was assigned on April 14, 2021. Dr. Daneshvar graduated from Mashhad University of Medical Sciences in 2002. Dr. Daneshvar holds Florida license MFC1839.

Dr. Daneshvar's primary practice is UF Health Shands Hospital, at 1600 SW Archer Rd, Gainesville, FL 32610 in Alachua County. The practice phone is (352) 265-8000.

Dr. Daneshvar's primary practice is UF Health Shands Hospital in Gainesville, Florida, part of UF Health. The medical group on file is UF Health Physicians. Dmand AI also links Dr. Daneshvar to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Daneshvar practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Daneshvar's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Daneshvar is licensed in Florida.

Dmand AI lists cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eyelid inflammation, glaucoma, glaucoma surgery and hereditary corneal conditions among the conditions Dr. Daneshvar treats.

CMS data shows 2,206 Medicare services from Dr. Daneshvar across 17 procedure codes in 2024, for 596 Medicare patients. Medicare paid $132,608 for them. Every service was in an office.

CMS counts 596 Medicare patients who saw Dr. Daneshvar in 2024. The largest group is 75 to 84, with 243 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Daneshvar's median patient age at 76, with 56% women.

In 2024, Dr. Daneshvar wrote 4,121 Medicare Part D claims for 671 patients. 72% of them were for generic drugs. CMS names the drug for 4,017 of them, across 25 drugs with 11 or more claims each, at $268,854 in total drug cost. In 2023, CMS named 3,205 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Daneshvar for performance year 2024, reported individually. Dr. Daneshvar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 32 procedures of cataract surgery by Dr. Daneshvar, more than 54% of the clinicians it reports for that procedure.

Dmand AI links 37 papers to Dr. Daneshvar, published from 2010 to 2024. 2020 was the busiest year, with 4. The most frequent topics are Intraocular Pressure, Glaucoma, Open-Angle and Tonometry, Ocular. Dr. Daneshvar has published most often in J Ophthalmic Vis Res. Dr. Daneshvar's most frequent co-authors are Nima Amini, MD, Reza Alizadeh, MD and Touka Banaee, MD.

CMS Open Payments shows 2 general payments to Dr. Daneshvar from 2 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Tarsus Pharmaceuticals, Inc. paid the most, $28.

Dr. Daneshvar graduated from Mashhad University of Medical Sciences in 2002. Dr. Daneshvar is a member of AAO, American Glaucoma Society and European Glaucoma Society.

Dr. Daneshvar is in network with 15 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Massachusetts. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.